FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019911789> ?p ?o ?g. }

• W2019911789 endingPage "1460" @default.
• W2019911789 startingPage "1449" @default.
• W2019911789 abstract "Recently, the inducible isoform of nitric oxide synthase has been shown to be an important immunomodulation molecule in allograft rejection. We have observed the production of nitric oxide during rejection and the effect of nitric oxide synthase inhibition on allograft rejection in a rat lung transplant model. Rat left lung allotransplants were performed in two strain combinations: brown Norway-to-F344 (major histocompatibility complex incompatible); and Lewis-to-F344 (minor loci incompatible) as severe and mild rejection models respectively. Syngeneic F344-to-F344 transplants were performed as a negative control. Nitric oxide production during rejection was determined by measuring the recipient's serum nitrite/nitrate levels as a stable end product of nitric oxide. The progression of rejection was evaluated radiographically and the grade of rejection was determined histologically. After operation, recipients of allotransplantation were randomly divided into two groups and received either aminoguanidine (200 mg/kg, intraperitoneal every 6 hours), a potent inducible nitric oxide synthase inhibitor, or normal saline treatment. The levels of serum nitrite and nitrate in recipients increased in the early phase of rejection in both allotransplant combinations. However, in the terminal phase of rejection, the serum nitrite/nitrate level decreased significantly compared with the peak level in the brown Norway-to-F344 recipients. The serum nitrite/nitrate levels in the syngeneic transplant recipients were normal during the entire observation period. In aminoguanidine-treated animals, serum nitrite/nitrate levels remained normal in both allograft combinations. Significant suppression of rejection in aminoguanidine-treated recipients was observed histologically and radiographically in comparison with untreated recipients in the brown Norway-to-F344 combinations. In the Lewis-to-F344 combination, aminoguanidine treatment significantly ameliorated histologic rejection but did not affect radiologic appearance. We therefore conclude nitric oxide is produced during early allograft rejection and may prove to be a marker and mediator of early rejection. The inhibition of inducible nitric oxide synthase results in significant reduction in rat lung allograft rejection." @default.
• W2019911789 created "2016-06-24" @default.
• W2019911789 creator A5001045635 @default.
• W2019911789 creator A5022229732 @default.
• W2019911789 creator A5041964655 @default.
• W2019911789 creator A5048361872 @default.
• W2019911789 creator A5063309650 @default.
• W2019911789 creator A5064688243 @default.
• W2019911789 creator A5070040722 @default.
• W2019911789 creator A5070668450 @default.
• W2019911789 date "1995-11-01" @default.
• W2019911789 modified "2023-10-11" @default.
• W2019911789 title "Inhibition of inducible nitric oxide synthase ameliorates rat lung allograft rejection" @default.
• W2019911789 cites W1490576088 @default.
• W2019911789 cites W1508898619 @default.
• W2019911789 cites W1565072410 @default.
• W2019911789 cites W1978756149 @default.
• W2019911789 cites W1980528903 @default.
• W2019911789 cites W1987875167 @default.
• W2019911789 cites W1994303699 @default.
• W2019911789 cites W1994389040 @default.
• W2019911789 cites W1998792901 @default.
• W2019911789 cites W2012386383 @default.
• W2019911789 cites W2016406628 @default.
• W2019911789 cites W2018809458 @default.
• W2019911789 cites W2025386529 @default.
• W2019911789 cites W2040150769 @default.
• W2019911789 cites W2043911718 @default.
• W2019911789 cites W2045846314 @default.
• W2019911789 cites W2048635427 @default.
• W2019911789 cites W2052385267 @default.
• W2019911789 cites W2056280592 @default.
• W2019911789 cites W2057025197 @default.
• W2019911789 cites W2075068003 @default.
• W2019911789 cites W2077081593 @default.
• W2019911789 cites W2077824574 @default.
• W2019911789 cites W2106310310 @default.
• W2019911789 cites W2137838799 @default.
• W2019911789 cites W2141493942 @default.
• W2019911789 cites W2164544057 @default.
• W2019911789 cites W2313326603 @default.
• W2019911789 cites W267694688 @default.
• W2019911789 cites W4232870685 @default.
• W2019911789 cites W4233127474 @default.
• W2019911789 doi "https://doi.org/10.1016/s0022-5223(95)70068-4" @default.
• W2019911789 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/7475197" @default.
• W2019911789 hasPublicationYear "1995" @default.
• W2019911789 type Work @default.
• W2019911789 sameAs 2019911789 @default.
• W2019911789 citedByCount "47" @default.
• W2019911789 countsByYear W20199117892012 @default.
• W2019911789 countsByYear W20199117892014 @default.
• W2019911789 countsByYear W20199117892017 @default.
• W2019911789 countsByYear W20199117892020 @default.
• W2019911789 countsByYear W20199117892023 @default.
• W2019911789 crossrefType "journal-article" @default.
• W2019911789 hasAuthorship W2019911789A5001045635 @default.
• W2019911789 hasAuthorship W2019911789A5022229732 @default.
• W2019911789 hasAuthorship W2019911789A5041964655 @default.
• W2019911789 hasAuthorship W2019911789A5048361872 @default.
• W2019911789 hasAuthorship W2019911789A5063309650 @default.
• W2019911789 hasAuthorship W2019911789A5064688243 @default.
• W2019911789 hasAuthorship W2019911789A5070040722 @default.
• W2019911789 hasAuthorship W2019911789A5070668450 @default.
• W2019911789 hasBestOaLocation W20199117891 @default.
• W2019911789 hasConcept C126322002 @default.
• W2019911789 hasConcept C178790620 @default.
• W2019911789 hasConcept C185592680 @default.
• W2019911789 hasConcept C203014093 @default.
• W2019911789 hasConcept C2776179834 @default.
• W2019911789 hasConcept C2776384668 @default.
• W2019911789 hasConcept C2777561873 @default.
• W2019911789 hasConcept C2777622882 @default.
• W2019911789 hasConcept C2777714996 @default.
• W2019911789 hasConcept C2911091166 @default.
• W2019911789 hasConcept C519581460 @default.
• W2019911789 hasConcept C71924100 @default.
• W2019911789 hasConcept C98274493 @default.
• W2019911789 hasConceptScore W2019911789C126322002 @default.
• W2019911789 hasConceptScore W2019911789C178790620 @default.
• W2019911789 hasConceptScore W2019911789C185592680 @default.
• W2019911789 hasConceptScore W2019911789C203014093 @default.
• W2019911789 hasConceptScore W2019911789C2776179834 @default.
• W2019911789 hasConceptScore W2019911789C2776384668 @default.
• W2019911789 hasConceptScore W2019911789C2777561873 @default.
• W2019911789 hasConceptScore W2019911789C2777622882 @default.
• W2019911789 hasConceptScore W2019911789C2777714996 @default.
• W2019911789 hasConceptScore W2019911789C2911091166 @default.
• W2019911789 hasConceptScore W2019911789C519581460 @default.
• W2019911789 hasConceptScore W2019911789C71924100 @default.
• W2019911789 hasConceptScore W2019911789C98274493 @default.
• W2019911789 hasIssue "5" @default.
• W2019911789 hasLocation W20199117891 @default.
• W2019911789 hasLocation W20199117892 @default.
• W2019911789 hasOpenAccess W2019911789 @default.
• W2019911789 hasPrimaryLocation W20199117891 @default.
• W2019911789 hasRelatedWork W1964604653 @default.
• W2019911789 hasRelatedWork W1972194921 @default.

• next